Received by email:

File: '\\doc\emailin\20200220 133535 Attachment Press Release - IME Q1 2020 Conf Call Notice)_final2.docx'






IMAGIN MEDICAL TO REPORT FIRST FISCAL QUARTER 2020 FINANCIAL
RESULTS ON FEBRUARY 27, 2019 - CONFERENCE CALL TO FOLLOW

Vancouver, B.C. and Boston, MA, February 20, 2020 - Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Sy
--->mbol: DPD2) ("Imagin" or the "Company") announced today that its financial results for the first fiscal quarter ended 
--->December 31, 2019, will be released after market close on Thursday, February 27, 2020. 

Imagin management will host a conference call at 5:00 p.m. ET to review the financial results and discuss business dev
--->elopments in the period.

Fiscal First Quarter 2020 Results Conference Call Details:
 
Date:  February 27, 2020
 
Time: 5:00 p.m. ET
 
Live Call: 844-369-8770 (Canada and the United States)
862-298-0840 (International)

Replay: 877-481-4010
Replay ID: 33144

The call will also be broadcast live and archived on the Company's website at www.imaginmedical.com under "Events & Pr
--->esentations."

About Imagin Medical
Imagin Medical is a surgical imaging company focused on advancing new methods of visualizing cancer during minimally i
--->nvasive procedures. The Company believes its first product, the i/Blue(TM) Imaging System, with its proprietary optics
---> and light sensors, will greatly increase the efficiency and accuracy of detecting cancer for removal, helping to redu
--->ce recurrence rates. The Company's initial focus is bladder cancer. Learn more at www.imaginmedical.com.

Forward-Looking Statement
Information set forth in this news release contains forward-looking statements. These statements reflect management's 
--->current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Company ca
--->utions that all forward- looking statements are inherently uncertain, and that actual performance may be affected by a
---> number of material factors, many of which are beyond the Company's control. Accordingly, actual and future events, co
--->nditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or impli
--->ed in the forward-looking information. Specifically, there is no assurance the Company's imaging system will work in 
the manner expected. Except as required under applicable securities legislation, the Company undertakes no obligation 
--->to publicly update or revise forward-looking information. 

The CSE has neither approved nor disapproved the information contained herein and does not accept responsibility for t
--->he adequacy or accuracy of this news release.

Contacts:

Stephen Kilmer, Investor Relations Telephone: 647-872-4849
Email: stephen@kilmerlucas.com

Jim Hutchens, President & CEO Telephone: 833-246-2446